Diagnostic value of CSF findings in antibody-associated limbic and anti-NMDAR-encephalitis
Authors:
- Michael P. MalterMMMichael P. Malter
- Christian E. ElgerCEChristian E. Elger
- Rainer SurgesRSRainer Surges
Open Access
- 1 March 2013
- journal article
- review article
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 22 (2) , 136-140
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Autoantibodies associated with diseases of the CNS: new developments and future challengesThe Lancet Neurology, 2011
- Autoimmune epilepsiesCurrent Opinion in Neurology, 2011
- Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitisThe Lancet Neurology, 2011
- Antibodies to glutamic acid decarboxylase define a form of limbic encephalitisAnnals of Neurology, 2010
- N‐methyl‐D‐aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargicaAnnals of Neurology, 2009
- CSF findings in patients with voltage gated potassium channel antibody associated limbic encephalitisJournal of the Neurological Sciences, 2008
- Paraneoplastic anti–N‐methyl‐D‐aspartate receptor encephalitis associated with ovarian teratomaAnnals of Neurology, 2007
- Recommended Standard of Cerebrospinal Fluid Analysis in the Diagnosis of Multiple SclerosisArchives of Neurology, 2005
- Potassium channel antibody‐associated encephalopathy: a potentially immunotherapy‐responsive form of limbic encephalitisBrain, 2004
- Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patientsBrain, 2000